Ultrastructurally "invasive" microvilli in an aggressively metastasizing biphasic malignant mesothelioma

Ultrastructural Pathology

Volumn 26, Issue 6, 2002, Pages 403-409

  Zu, Youli ^a   Sidhu, Gurdip S ^a,b   Wieczorek, Rosemary ^a   Cassai, Nicholas D ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Biphasic; Electron microscopy; Invasive microvilli; Localized malignant mesothelioma; Metastasis; Ultrastructure

Indexed keywords

AGED; ARTICLE; AUTOPSY; CANCER INVASION; CASE REPORT; CELL SURFACE; CYTOPLASM; DESMOSOME; DISEASE COURSE; HUMAN; HUMAN TISSUE; LOBECTOMY; MALE; MALIGNANT MESOTHELIOMA; METASTASIS; MICROVILLUS; PLEURA TUMOR; PRIORITY JOURNAL; TUMOR CELL;

ADRENAL GLAND NEOPLASMS; AGED; DIGESTIVE SYSTEM NEOPLASMS; HEART NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MICROVILLI; NEOPLASM INVASIVENESS; PLEURAL NEOPLASMS;

EID: 0036866940     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/01913120290104719     Document Type: Article

References (43)

1. Atlas of Tumor Pathology: Tumors and Pseudotumors of the Serous Membranes. McCaughey WTE, Kannerstein M, Churg J, eds. Washington DC: Armed Forces Institute of Pathology; 1995:15-88.
2. Battifora H. The pleura, In: Sternberg SS, ed. Diagnostic Surgical Pathology, Ed. 3., New York: Raven Press; 1999:1117-1143.
3. Bolen JW. Tumors of serosal tissue origin. Clin Lab Med. 1987;7:31-50.
4. Clarke C. Experimental mesothelium Anat Rec. 1915-1916;10:301-316.
5. Dardick I, Srigley JR, McCaughey WT, et al. Ultrastructural aspects of the histogenesis of diffuse and localized mesothelioma. Virchows Arch A Pathol Anat Histopathol. 1984;402:373-388.
6. Maximow A. Uber das Mesothel (Deckzellen der serosen Haute) und die Zellen der serosen Exsudate. Untersuchungen an entzundetem Gewebe und an Gewebskulturen. Arch Exp Zellforsch. 1927;4:1-36.
7. Whitaker D, Papadimitriou JM, Walters MN. The mesothelium and its reactions: A review. Crit Rev Toxicol 1982;10:81-84.
8. Wills EJ. Pleural mesothelioma with initial presentation as cervical lymphadenopathy. Ultrastruct Pathol 1995;19:389-394.
9. Sidhu GS. The ultrastructure of malignant epithelial neoplasms of the lung. In: Sommers SC: Rosen PP, eds. Pathol Annu., Norwalk, CT: Appleton-Century Crofts; 1982:235-266.
10. Burns TR, Greenberg D, Mace ML, et al. Ultrastructural diagnosis of epithelial malignant mesothelioma. Cancer. 1985;56:2036-2040.
11. Dardick I, Jabi M, McCaughey WTE, et al. Diffuse epithelial mesothelioma: A review of the ultrastructural spectrum. Ultrastruct Pathol. 1987;11:503-533.
12. Davis JMG. Ultrastructure of human mesotheliomas. J Natl Cancer Inst. 1974;52:1715-1725.
13. Lehto V-P, Virtanen I. Intermediate (10 nm) filaments in human malignant mesothelioma. Virchows Arch B 1978;28:229-234.
14. Suzuki Y. Pathology of human malignant mesothelioma. Semin Oncol. 1980;8:268-282.
15. Suzuki Y, Churg J, Kannerstein M. Ultrastructure of human malignant diffuse mesothelioma. Am J Pathol. 1976;85:241-262.
16. Sakuma N, Kamei T, Ishihara T. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant pleural effusions as compared with reactive mesothelial cells. Acta Cytol. 1999;43:777-785.
17. Sidhu GS, Fresko O. Adenomatoid tumor of the epididymis: Ultrastructural evidence of its biphasic nature. Ultrastruct Pathol. 1980;1:39-47.
18. Bedrossian CW, Bonsib S, Moran C. Differential diagnosis between mesothelioma and adenocarcinoma: A multimodal approach based on ultrastructure and immunocytochemistry. Semin Diagn Pathol. 1992;9:124-140.
19. Oury TD, Hammar SP, Roggli VL. Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol. 1998;29:1382-1392.
20. Warhol MJ, Corson JM. An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast. Hum Pathol. 1985;16:50-55.
21. Warhol MJ, Hickey WF, Corson JM. Malignant mesothelioma: Ultrastructural distinction from adenocarcinoma. Am J Surg Pathol. 1982;6:307-314.
22. Wick MR, Loy T, Mills SE, et al. Malignant epithelial pleural mesothelioma versus peripheral pulmonary adenocarcinoma: A histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol. 1990;21:759-766.
23. Dardick I, Al-Jabl M, McCaughey WT, et al. Ultrastruct Pathol. 1984;7:151-160.
24. Wasilewska A, Rys J, Niezabitowski A. Ultrastructure of diffuse malignant mesothelioma of the pleura: An analysis of ten cases. Patol Pol. 1993;44:95-100.
25. Carstens PH. Contact between abluminal microvilli and collagen fibrils in metastatic adenocarcinoma and mesothelioma. J Pathol. 1992;166:179-182.
26. Dewar A, Valente M, Ring NP, et al. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparison. J Pathol. 1987;152:309-316.
27. Ghadially FN, McCaughy WT, Perkins DG, et al. Diagnostic value of microvillus-matrix associations in tumors. J Submicrosc Cytol Pathol. 1992;24:103-108.
28. Leong AS, Stevens MW, Mukherjee TM. Malignant mesothelioma: Cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation. Semin Diagn Pathol. 1992;9:141-150
29. Blobel GA, Moll R, Franke WW, et al. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol. 1985;121:235-247.
30. Borrow M, Conston A, Livornese L, et al. Mesothelioma following exposure to asbestos: A review of 72 cases. Chest. 1973;64:641-646.
31. McDonald JC. Cancer risks due to asbestos and man-made fibers. Recent Results Cancer Res. 1990;120:122-131.
32. Newhouse M. Epidemiology of asbestos-related tumors. Semin Oncol. 1981;8:250-257.
33. Rogers AJ, Leigh J, Berry G, et al. Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma. Cancer. 1991;67:1912-1920.
34. Selikoff IJ, Churg J, Hammond EC. Relation between exposure to asbestos and mesothelioma. N Engl J Med. 1965;272:560-565.
35. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Industr Med. 1960;17:260-271.
36. Churg A. Neoplastic asbestos-induced diseases. In: Chur A, Green F, eds. Pathology of Occupational Lung Disease. New York: Igaku-Shoin; 1988;279
37. Battifora H. Diagnostic uses of antibodies to keratins: A review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. In: Fenoglio C, Wolff M, Rilke F, eds. Progress in Surgical Pathology. New York: Masson; 1987;1-15.
38. Bejui-Thivolet F, Patricot LM, Vauzelle JL, et al. Keratins in malignant mesotheliomas and pleural adenocarcinomas: Comparative immunohistochemical analysis with polyclonal and monoclonal antibodies. Pathol Res Pract. 1984;179:67-73.
39. Debus E, Moll R, Franke WW, et al. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol. 1984;114:121-130.
40. Osborn M, Weber K. Intermediate filaments: Cell-type-specific markers in differentiation and pathology. Cell. 1982;31:303-806.
41. Ramaekers FCS, Huysmans A, Moesker O, et al. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors: Use in surgical pathology. Lab Invest. 1983;49:353-361.
42. Ramaekers FCS, Puts JJG, Kant A, et al. Use of antibodies to intermediate filaments in the characterization of human tumors. Cold Spring Harbor Symp Quant Biol. 1982;66:331-339.
43. Ghadially FN. Microvilli in mesothelioma and adenocarcinoma. In: Ultrastructural Pathology of the Cell and Matrix, Ed. 4. Boston: Butterworth-Heinemann 1997;1240-1251.